77
Views
15
CrossRef citations to date
0
Altmetric
Original Research

S100A16 regulated by Snail promotes the chemoresistance of nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway

, , , , &
Pages 2449-2456 | Published online: 27 Mar 2019

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
  • Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer. Lancet. 2016;388(10061):2796–2810. doi:10.1016/S0140-6736(16)30512-827345655
  • Huncharek M, McGarry R, Kupelnick B. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Anticancer Res. 2001;21(1b):765–769. 11299841
  • Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001;33:637–668. 11390274
  • Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci. 2002;7:d1356–1368. 11991838
  • Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech. 2003;60(6):540–551. doi:10.1002/jemt.1029612645002
  • Donato R, Sorci G, Giambanco I. S100A6 protein: functional roles. Cell Mol Life Sci. 2017;74(15):2749–2760. doi:10.1007/s00018-017-2526-928417162
  • Hongyan Chen CX, Qing’e Jin ZL. S100 protein family in human cancer. Am J Cancer Res. 2014;4(2):89–115. 24660101
  • Agerbaek M, Alsner J, Marcussen N, et al. Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients. Eur Urol. 2006;50(4):777–785. doi:10.1016/j.eururo.2006.02.02716632178
  • Kim JH, Park J. Prognostic significance of heme oxygenase-1, S100 calcium-binding protein A4, and syndecan-1 expression in primary non-muscle-invasive bladder cancer. Hum Pathol. 2014;45(9):1830–1838. doi:10.1016/j.humpath.2014.04.02024957789
  • Yao R, Davidson DD, Lopez-Beltran A, et al. The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol. 2007;22(9):1025–1032. doi:10.14670/HH-22.102517523080
  • Lee J, Wysocki PT, Topaloglu O, et al. Epigenetic silencing of S100A2 in bladder and head and neck cancers. Oncoscience. 2015;2(4):410–418. doi:10.18632/oncoscience.14026097874
  • Wang C, Li A, Yang S, et al. CXCL5 promotes mitomycin C resistance in non-muscle invasive bladder cancer by activating EMT and NF-kappaB pathway. Biochem Biophys Res Commun. 2018;498(4):862–868. doi:10.1016/j.bbrc.2018.03.07129545183
  • Zheng J, Zhu X, Zhang J. CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migration. Biochem Biophys Res Commun. 2014;446(1):18–24. doi:10.1016/j.bbrc.2014.01.17224583128
  • Ridinger K, Ilg EC, Niggli FK, et al. Clustered organization of S100 genes in human and mouse. Biochim Biophys Acta. 1998;1448(2):254–263. 9920416
  • Marenholz I, Heizmann CW. S100A16, a ubiquitously expressed EF-hand protein which is up-regulated in tumors. Biochem Biophys Res Commun. 2004;313(2):237–244. 14684152
  • Mani J, Vallo S, Rakel S, et al. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101). BMC Cancer. 2015;15:224. doi:10.1186/s12885-015-1584-325885284
  • Sturchler E, Cox JA, Durussel I, et al. S100A16, a novel calcium-binding protein of the EF-hand superfamily. J Biol Chem. 2006;281(50):38905–38917. doi:10.1074/jbc.M60579820017030513
  • Sun X, Wang T, Zhang C, et al. S100A16 is a prognostic marker for colorectal cancer. J Surg Oncol. 2018;117(2):275–283. doi:10.1002/jso.2482228876468
  • Saxena M, Stephens MA, Pathak H, et al. Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis. 2011;2(7):e179. doi:10.1038/cddis.2011.8221734725
  • Zhou W, Pan H, Xia T, et al. Up-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancer. J Biomed Sci. 2014;21:97. doi:10.1186/s12929-014-0097-825287362
  • Katono K, Sato Y, Kobayashi M, et al. S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma. Onco Targets Ther. 2017;10:5273–5279. doi:10.2147/OTT.S14507229138580
  • Tanaka M, Ichikawa-Tomikawa N, Shishito N, et al. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion. BMC Cancer. 2015;15:53. doi:10.1186/s12885-015-1584-325884418